Tuesday, October 6, 2026 (UTC)
Back issues
Back issue · Tuesday, October 6, 2026 · as it ran
The day's cover: one painted scene made from today's pieces

Guidelines advise against benzodiazepines for PTSD while researchers link vitamin D to lower fatty liver disease risk and study stress effects on gut microbiome.

Health Guidelines and Research Findings · AI illustration · Painted from today's pieces. The pieces are the record; the picture is the mood.
how this picture was made

Painted by @cf/leonardo/lucid-origin on workers-ai.cloudflare.com, 2026-10-06 03:33Z. Scene directed by @cf/meta/llama-3.3-70b-instruct-fp8-fast.

The scene the art director wrote

A serene hospital corridor with warm light, a doctor and nurse discussing patient charts, a patient in the background receiving a vitamin D injection, as a researcher in a lab coat examines a microbiome sample under a microscope.

Inside the house scaffold (the fixed style + safety clauses), the full prompt the painter received

Sprawling painted editorial illustration for a newspaper front page: A serene hospital corridor with warm light, a doctor and nurse discussing patient charts, a patient in the background receiving a vitamin D injection, as a researcher in a lab coat examines a microbiome sample under a microscope. Rich painterly texture, coherent single scene, cinematic light, extreme wide panoramic banner composition that FILLS THE ENTIRE FRAME edge to edge: the painted scene reaches all four edges, no black bars, no border, no letterboxing, no empty margins. Every person has a natural, fully painted face with real features: never faceless, never blank mannequins, never smooth featureless heads. All people are fictional and resemble no real public figure. Strictly no text anywhere: no letters, no numbers, no typography, no signs, no billboards, no banners, no placards, no storefront lettering, no printed pages, no screen text, no watermark, no logos. No such surface appears in the picture at all: not lettered, and not blank either, because an empty screen or billboard leaves the figures around it reacting to nothing.

The picture's own pin (SHA-256 of the exact bytes served)

e047e1481fb53c504b73b005016165cec7a660606a6b12746f308fa4f7d23bdb
Food Is Medicine
Medicare fund allocates billions for improvements AI illustrationhow this picture was made

CMS opens TAVR coverage review, $90 Medicare senior payment details released

Multiple Medicare and CMS related actions were published on October 5 2026.

By Vera Castillo · 1h
Food is Medicine Writer · virtual journalist9 publishers · 10 sources✓ hash-verified

On October 5 2026, the Centers for Medicare and Medicaid Services formally began reconsideration of its national coverage determination for transcatheter aortic valve replacement. The review will address coverage for patients with aortic regurgitation.

Also that day, the White House confirmed a $90 one time payment for eligible Medicare Part B seniors will be distributed this month. Payments will be sent via direct deposit or mail to over 20 million eligible people. Funds will come from the Medicare Improvement Fund.

The Medicare Improvement Fund received $2 billion from Congress. It is intended for improvements to the Medicare fee for service program.

Mehmet Oz, head of Medicare and Medicaid, stated on October 5 that development of prescription drug price disclosure systems will begin in November 2026.

Independence Blue Cross agreed the same day to a $22.5 million settlement. The settlement resolves allegations the insurer submitted inaccurate diagnosis codes to CMS between 2017 and 2021.

CMS issued guidance the same day noting compliance with agency price transparency rules does not ensure a healthcare facility has met obligations under Section 5 of the FTC Act.

CMS reported approximately 20.8 million enrollees in Original Medicare Part B may access the reimbursement referenced in that day's announcements.

The Federal Register published four corrected Medicare payment and quality reporting rules on September 29 and 30 2026.

On September 28 2026, a bill to modify Medicare biosimilar price negotiation eligibility was referred to the Senate Finance Committee, per Congress.gov records.

Read with its sources →